Structure Therapeutics (GPCR) Analyst & Key Data

Analyst Consensus

Buy12 analysts

Buy

Updated Sep 12, 2026

Total Analysts12

Buy

14

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$38.66

Median Target+160.61%

$100.75

Potential upside vs current price

DCF Value-65.92%

$13.18

Potential downside vs current price

Current Stock Price

$38.66

Median Target+160.61%

$100.75

Potential upside vs current price

DCF Value-65.92%

$13.18

Potential downside vs current price

Analyst Consensus

Buy12 analysts

Buy

Updated Sep 12, 2026

Total Analysts12

Buy

14

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$38.66

Median Target+160.61%

$100.75

Potential upside vs current price

DCF Value-65.92%

$13.18

Potential downside vs current price

Current Stock Price

$38.66

Median Target+160.61%

$100.75

Potential upside vs current price

DCF Value-65.92%

$13.18

Potential downside vs current price

Structure Therapeutics Inc.